Autism Impact Fund: Investing in innovative autism services and life science breakthroughs.
9
Operating
2021
Orlando, FL, US
Autism Impact Fund (AIF) is dedicated to investing in innovative autism services and life science breakthroughs. The fund focuses on life science advancements, therapeutics, and service companies that enhance the lives of individuals with autism spectrum disorder (ASD) and related conditions. AIF aims to create a world where diagnosis for neurodevelopmental disorders is achievable with a simple blood test, behavioral therapy is clinically validated and data-driven, and microbiome-targeted therapeutics improve nervous system function.
AIF has made significant strides by supporting companies across various stages, from seed to Series C funding. Their portfolio includes ventures that are pioneering accessible care for individuals with disabilities and advancing diagnostic and therapeutic solutions. Through strategic investments, AIF is driving impactful changes in the autism community, fostering an environment where innovative solutions can thrive and improve the quality of life for those affected by ASD.
Portfolio Snapshot
Recorded participation and recipient operating status, not current holdings or realized exits
Recorded Recipients9
Repeat Participations3
Operating Recipients9
Top Investment Stages
Seed2 (25.0%)
Series A2 (25.0%)
Series C2 (25.0%)
Series B1 (12.5%)
Series D1 (12.5%)
Stage Mix
Seed 25%Series A 25%Series C 25%Series B 13%Series D 13%
Concentration shown as share of disclosed investments by stage.
